STUDresearch · Peptide
MGF / PEG-MGF
Also known as
Mechano Growth Factor · PEGylated MGF · IGF-1Ec
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Some talk
Mixed
IM / SubQ
Growth factors / muscle
Mixed — Local/systemic IGF-splice variant research chem culture.
What people say
This combined card covers non-PEG MGF and PEG-MGF research products discussed for muscle repair. Product labels may refer to different constructs, and a PEGylated product cannot inherit a non-PEG peptide's identity or kinetics.
Doses people talk about
These are descriptive self-reports, not a progression. PEG and non-PEG products are distinct, product identity was unverified, and bilateral wording must not be converted into a per-side amount.
How it may feel
Reports conflict: one older PEG-MGF user described immediate fullness, while newer users described severe injection pain, no benefit, or possible recovery. Injury and recovery stories were often stacked or otherwise confounded.
Initial PEG-MGF forum log120 mcg after training
The author described immediate fullness in a short initial post; there was no controlled comparator or durable follow-up in the reviewed text.
Later PEG-MGF forum report200 mcg four times weekly
A later commenter described fullness without a diet change, but the uncontrolled report could not establish new muscle or isolate training effects.
Non-PEG MGF reply200 mcg reported bilaterally
The wording did not resolve whether 200 mcg was the total or the amount in each biceps; no per-side conversion is made.
Half-life & effect duration
- Half-life in the body
- MGF · community estimatesAbout 5–7 minutes; wider reports 2–15 minutes
- PEG-MGF · common community estimateAbout 48–72 hours
- PEG-MGF · other community estimates24+ hours or about 5 days
- Felt duration people report
- One PEG-MGF accountImmediate fullness
- Other accountsSevere injection pain, no benefit or uncertain recovery in stacks
Cycles people discuss
Public use is described in short, training-linked experiments rather than a validated clinical cycle. Multi-week on/off patterns are cost- and caution-driven community practice, not an established schedule.
Timing
Inspected PEG-MGF reports placed use after training or four times weekly, while broader MGF notes organize use around workout days across multi-week blocks. Local versus systemic timing remains debated, not validated.
Stacks
Reports involving BPC-157, TB-500, IGF products or changing training cannot isolate MGF or PEG-MGF. Solo and stacked accounts should not be pooled as equivalent evidence.
Watch for
Unknowns: Long-term safety for gray-market preparations is often poorly characterized.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
A human parent-plasma half-life is not established here for either exact PEG-MGF or synthetic 24-amino-acid MGF product.
The formal literature reviewed distinguishes endogenous IGF-1 splice transcripts, synthetic E-domain peptide experiments and product constructs; it does not provide a transferable human elimination value for the gray-market products in the reports.
Absence from this bounded source set is not proof no PK study exists. Product sequence, PEG attachment and identity were not independently verified.
- Matheny et al. — Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration (opens in a new tab)Review distinguishes IGF-IEb transcript biology from synthetic 24-amino-acid E-peptide experiments and notes that an analogous endogenous peptide product had not been identified in cells, tissues or fluids.Narrative review, not an exact-product analytical assay, human PK study or test of the products described in forum posts.
- Fornaro et al. — Mechano-growth factor peptide, the COOH terminus of unprocessed insulin-like growth factor 1, has no apparent effect on myoblasts or primary muscle stem cells (opens in a new tab)Primary in-vitro paper tested synthetic 24-amino-acid MGF E peptide and reported no increased proliferation in C2C12 myoblasts or primary human skeletal-muscle myoblasts/stem cells under its conditions.Cell-culture work on a specified synthetic peptide, not a human injection, PEG-MGF PK study or physique outcome trial.
- Kandalla et al. — Mechano growth factor E peptide enhances proliferative life span and delays senescence in human muscle progenitor cells (opens in a new tab)Primary in-vitro paper reported increased proliferative life span and delayed senescence in neonatal and young-adult human muscle cells, but not old-adult cells.Donor-cell experiment, not in-vivo efficacy, parent-plasma PK, a PEGylated construct or a community-product identity assay; it conflicts with other cell work.
Felt duration people report
The inspected accounts do not establish a consistent onset or felt-duration window.
One older user described immediate fullness after 120 mcg PEG-MGF, while newer accounts described severe injection pain, no benefit, or uncertain recovery on stacked products.
Anonymous self-reports, unverified compounds, sparse follow-up and training, injury and co-compound confounding prevent prevalence or duration estimates.
- IronMagazine Forums — PEG MGF users (opens in a new tab)Thread includes a first-use 120 mcg post-training PEG-MGF report with immediate fullness and a later 200 mcg four-times-weekly account; participants debate workout versus off-day timing.Anonymous bodybuilding forum, old thread, unverified products, brief follow-up and uncontrolled training/diet; cannot establish efficacy, tissue gain or PK.
- Reddit r/BodyHackGuide — Experience with PEG-MGF (opens in a new tab)Comments include severe injection pain with no benefit, a BPC/TB/PEG-MGF recovery account, a non-PEG MGF reply worded as 200 mcg bilaterally in each biceps, and a veteran's mostly fruitless MGF view.Anonymous mixed discussion with promotional content, unverified products, unresolved bilateral dose wording and major stack/injury confounding.
What people say
- Mixed recovery and fullness reports: One short PEG-MGF log described immediate fullness, while newer commenters ranged from painful injection with no benefit to possible strain recovery; stacked BPC/TB use and training confound attribution. Independent cell studies of the synthetic 24-amino-acid MGF peptide also conflict. forum
- Body-comp talk: MGF / PEG-MGF is discussed for recomp, strength continuity, or soft-tissue recovery depending on class. forum
- Training confound: PRs and scale changes almost always co-travel with diet phase and programming. anecdote
- Suppression / lipid chatter: Hormonal agents pull bloodwork and PCT conversations even when marketed “mild.” forum
- Cycle thinking: Fixed on/off blocks dominate over indefinite daily use. forum
Doses people talk about
- Inspected PEG-MGF reports plus broader legacy band: One first-use forum log reported 120 mcg after training; a later user in the thread reported 200 mcg four times weekly. Broader legacy talk remains ~200–400 mcg per injection, often 2–3×/week. forum
- Inspected non-PEG MGF report plus broader legacy band: One reply described 200 mcg bilaterally in the biceps but did not resolve whether 200 mcg was total or per side. Broader legacy talk remains ~100–300 mcg local peri-workout. forum
- Cycle: multi-week training blocks; local vs systemic pin debates are constant. forum
- Framing: MGF / PEG-MGF research-chem IGF-axis talk — not clinical standard of care. forum
How it may feel
- Early inspected reports: Injection-site pain or no clear acute effect can dominate; one older first-use PEG-MGF log described immediate fullness, while another user reported no benefit. No reviewed account here used an oral product. forum
- Training blocks: Days around workouts. forum
- Day 1: Most people notice logistics (route, sting, GI) more than a “miracle” effect from MGF / PEG-MGF. forum
- Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
- Weeks 1–2: First honest checkpoint in self-logs. forum
Cycles people discuss
- Short experimental: community forum
- Common pattern: Many self-protocols use weeks-on / weeks-off rather than indefinite daily use — cost and caution drive this more than hard science. forum
- No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
- Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum
Timing
- Parent-peptide PK: PEGylation is discussed as extending exposure versus non-PEG MGF, but the reviewed sources did not establish a human parent-plasma half-life for either the exact gray-market PEG-MGF construct or the synthetic 24-amino-acid MGF peptide. forum
- Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
- Published PK: Where human PK exists it should override forum half-life memes for MGF / PEG-MGF. trial
More on what it is
- What it is: Mechano growth factor (IGF-1 Ec) and PEGylated MGF variants discussed for local muscle repair. forum
- See also: Separate `mgf` / `peg-mgf` cards may exist. forum
- Research posture: Educational summary of public discussion and literature themes only. forum
- How people talk about it: Forum volume is a popularity signal for MGF / PEG-MGF, not proof it works for you. forum
- Research only: Not approved advice for self-experimentation; legality and access vary by place. forum
Stacks
- With PEG-IGF-1 / training: community forum
- Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Lumps / IGF risks theoretically: community forum
- General caution: Research chemical and compounded sources vary; adverse events may be under-reported. forum
- Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
- Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
- Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
- Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.